WETTIG THANE (Chief Commercial Officer) reported 2 transactions at KYNTRA BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/9/2025ACC: 0001415889-25-024012
Officer· Chief Commercial Officer
Since Jun 2020
-494.00
Net shares
Net seller
$4.9K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
494.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−246.00
Price / share
$7.83
Trade value
$1.93K
% of position
1.1%
6/6/2025
21.73K→21.49K
Common Stock
Direct
Shares
−248.00
Price / share
$12.10
Trade value
$3K
% of position
1.2%
9/6/2025
21.49K→21.24K
Total
Net shares
−494.00
Net value
-$4.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2025 | F · Tax Withholding | −246.00 | $7.83 | $1.93K | 1.1% | 21.73K | 21.49K |
| Common Stock Direct | 9/6/2025 | F · Tax Withholding | −248.00 | $12.10 | $3K | 1.2% | 21.49K | 21.24K |
| Total | −494.00 | -$4.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.00
Total
40.00 indirect40.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.00 | Indirect |
| Total | 40.00 | 40.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported